Sign up for a free trial now

Login
Subscribe
Take a FREE Trial

About Us
Contact us
RSS

25 May 2013

Search

The Pharma Letter

Home
7 Day Premium Trial
Pharmaceuticals
Biotechnology
Generics
Events
Companies
Drugs
Subscribe

Apeiron Biologics Articles

There are no articles related to Apeiron Biologics.

Hot Topics
Most Read

Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
Proposal to list Roche's Neulastim and Actemra in New Zealand
Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth

Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
Proposal to list Roche's Neulastim and Actemra in New Zealand
Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth

© 2013 thepharmaletter.com

Home
RSS
About Us
Subscribe
Terms and Conditions
Article Archive

Site powered by WORKSsitebuilder CMS